Jim Cramer’s Recent Takes on These 12 Stocks

3. Baxter International Inc. (NYSE:BAX)

Number of Hedge Fund Holders: 31

Baxter International Inc. (NYSE:BAX) is one of the stocks Jim Cramer recently gave takes on. A caller asked whether they should continue to hold or sell the stock, and Cramer commented:

“Oh my god, you know, Baxter, go buy Abbott Labs. I mean, I gotta tell you, Baxter’s been such an incredible disappointment. It’s painful. I don’t know why they continue to disappoint. They are the king of disappointment, and that’s saying something. I’m, you know, the knight of disappointment or the bishop. They’re the king.”

Baxter International Inc. (NYSE:BAX) provides medical devices, pharmaceuticals, and digital health technologies used across hospitals, clinics, and home care. Its products include IV solutions, infusion systems, surgical products, respiratory devices, and specialty injectables. Here is what Parnassus Investments has to say about Baxter International Inc. (NYSE:BAX) in its second-quarter 2025 investor letter:

“Despite Baxter International Inc.’s (NYSE:BAX) defensive characteristics, we became concerned about its capital allocation decisions, recent management changes and sensitivity to hospital budgets. We traded Baxter for Linde, where we see higher long-term risk-reward potential.”